361 related articles for article (PubMed ID: 16919307)
1. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
Cavicchioni G; Fraulini A; Falzarano S; Spisani S
Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
[TBL] [Abstract][Full Text] [Related]
2. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.
Spisani S; Fraulini A; Varani K; Falzarano S; Cavicchioni G
Eur J Pharmacol; 2007 Jul; 567(1-2):171-6. PubMed ID: 17481605
[TBL] [Abstract][Full Text] [Related]
3. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
4. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
[TBL] [Abstract][Full Text] [Related]
5. Conformational investigations on analogs of inflammation response inducing chemotactic tripeptide fMLP.
Rathore RS
Biopolymers; 2005; 80(5):651-64. PubMed ID: 15648091
[TBL] [Abstract][Full Text] [Related]
6. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
Lucente G; Giordano C; Sansone A; Torino D; Spisani S
Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Spisani S; Giuliani AL
Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
[TBL] [Abstract][Full Text] [Related]
10. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
[TBL] [Abstract][Full Text] [Related]
11. New chemotactic peptide analogs with high biological activity for human neutrophils.
Spisani S; Traniello S; Giuliani AL; Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Pochetti G; Lucente G
Biochem Int; 1992 May; 26(6):1125-35. PubMed ID: 1321622
[TBL] [Abstract][Full Text] [Related]
12. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
Giordano C; Lucente G; Mollica A; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Spisani S
J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138
[TBL] [Abstract][Full Text] [Related]
13. Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
Cavicchioni G; Turchetti M; Spisani S
Bioorg Med Chem Lett; 2001 Dec; 11(24):3157-9. PubMed ID: 11720864
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S
Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595
[TBL] [Abstract][Full Text] [Related]
15. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
16. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Paci M; Sette M; Di Nola A
Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
[TBL] [Abstract][Full Text] [Related]
18. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
19. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S
Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
